FDA Regional Offices Will Close Under ORA Reorganization
This article was originally published in The Gray Sheet
Executive Summary
All regional offices within FDA's Office of Regulatory Affairs will close effective Oct.1 as part of an ongoing reorganization
You may also be interested in...
Revitalizing FDA’s Office Of Regulatory Affairs Means ‘Buying’ Some Expertise
After years of shrinking resources and workforce attrition, FDA's Office of Regulatory Affairs plans to aggressively recruit new staff to meet the emerging challenges of more complex products and overseas manufacturing
Revitalizing FDA’s Office Of Regulatory Affairs Means ‘Buying’ Some Expertise
After years of shrinking resources and workforce attrition, FDA's Office of Regulatory Affairs plans to aggressively recruit new staff to meet the emerging challenges of more complex products and overseas manufacturing
FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts
FDA's Office of Regulatory Affairs still plans to reorganize, despite its recent decision to cancel the planned closure of seven field labs